Using skin models to assess the effects of a pre-work cream: Methodological aspects and perspective of the industry

Current Problems in Dermatology

Volumn 34, Issue , 2007, Pages 19-32

  Zur Mühlen, Annette ^a   Klotz, A ^a   Allef, P ^a   Weimans, S ^a   Veeger, M ^a   Thorner B ^a   Eichler, J O ^a  

^a EVONIK INDUSTRIES AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MODEL; CELL SURVIVAL; CLINICAL TRIAL; CULTURE TECHNIQUE; DRUG DOSAGE FORM; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OCCUPATIONAL ECZEMA; PATHOLOGY; SKIN; TOXICITY TESTING;

ADOLESCENT; ADULT; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DERMATITIS, OCCUPATIONAL; DERMATOLOGIC AGENTS; DOSAGE FORMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SKIN; SKIN IRRITANCY TESTS;

EID: 33847417476     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000099601     Document Type: Article

References (43)

1. Diepgen TL, Coenraads PJ: The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 1999;73:496-506.
2. Kucharekova M, Schalkwijk J, van de Kerkhof PCM, van der Valk PGM: Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis 2002;46:331-338.
3. Kresken J, Klotz A: Occupational skin protection products - A review. Int Arch Occup Environ Health 2003;76:355-358.
4. Zhai H, Maibach H: Efficacy of barrier creams; in Maibach H, Elsner P (eds): Cosmeceuticals. New York, Decker, 2000, pp 249-264.
5. Schnetz E, Diepgen TL, Elsner P, Frosch PJ, Klotz AJ, Kresken J, Kuss O, Merk H, Schwanitz HJ, Wigger-Alberti W, Fartasch M: Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation. Contact Dermatitis 2000;42:336-343.
6. Klotz A, zur Mühlen A, Thörner B, Kietzmann M, Holtmann W, Pittermann W: Testing the efficacy of skin protection products in vivo and in vitro. SÖFW J 2003;9:10-16.
7. Wertz P, Downing DT: Ceramides of pig epidermis: structure determination. J Lipid Res 1983;24:759-765.
8. Roguet R: The use of standardized human skin models for cutaneous pharmatoxicology studies. Skin Pharmacol Appl Skin Physiol 2002;15:1-3.
9. Ponec M, Boelsma E, Gibbs S, Mommaas M: Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002;15:4-17.
10. Eichler JO, Hey S: Das humane 3D Hautmodell als Testsystem für das Reizpotential von Arbeitsstoffen. Internationaler Hautschutztag 2006, available from www.krefelder-hautschutztag.de.
11. Ponec M, Weerheim A, Mulder A, Gooris G, Bouwstra J, Mommaas M: The formation of competent barrier lipids in the reconstructed epidermis requires the prevalence of vitamin C. J Invest Dermatol 1997;109:348-355.
12. Ponec M, Boelsma E, Weerheim A: Covalent bound lipids in reconstructed human epithelia. Acta Derm Venereol 2000;80:89-93.
13. Bouwstra J, Gooris G, Weerheim A, Kempenaar J, Ponec M: Characterisation of stratum corneum structure in reconstructed epidermis by X-ray diffraction. J Lipid Res 1995;36:496-504.
14. Ponec M, Gibbs S, Pilgram G, Boelsma E, Koerten H, Bouwstra J, Mommaas M: Barrier function in reconstructed epidermis and its resemblance to native human skin. Skin Pharmacol Appl Skin Physiol 2001;14:63-71.
15. Kresken J, Klotz A, Rosenberger V: Gewerblicher Hautschutz: Wirksamkeitsprüfung nichtwassermischbarer Hautschutzsalben im repetitiven Irritationstest (RIT); in Braun-Falco O, Gloor M, Korting HC (eds): Nutzen und Risiko von Kosmetika. Berlin, Springer, 2000, pp 41-46.
16. Pinnagoda J, Tupker RA, Agner T, Serup J: Guidelines for transepidermal water loss (TEWL) measurements. Contact Dermatitis 1990;22:164-178.
17. zur Muehlen A, Klotz A, Veeger M, Thörner B, Weimans S, Diener B, Hermann M, Coppotelli A: Using skin models to assess the effects of a skin care emulsion on skin barrier function. Cosmet Toiletries 2004;119:81-85.
18. Greif C, Wigger-Alberti W, Elsner P: Emollients and barrier creams in the prevention of hand eczema; in Maibach HI, Menné T (eds): Hand Eczema. Boca Raton, CRC Press, 2000, pp 323-331.
19. Ramsing DW, Agner T: Preventive and therapeutic effects of a moisturizer: an experimental study of human skin. Acta Derm Venereol 1997;77:335-337.
20. De Paepe K, Hachem JP, Vanpee E, Goossens A, Germaux MA, Lachapelle JM, Lambert J, Matthieu L, Roseeuw D, Suys E, Hecke EV, Rogiers V: Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally elicited irritant and allergic contact dermatitis. Contact Dermatitis 2001;44:337-343.
21. Faller C, Bracher M: Reconstructed skin kits: reproducability of cutaneous irritancy testing. Skin Pharmacol Appl Skin Physiol 2002;15:74-91.
22. Fletcher ST, Baker VA, Fentem JH, Basketter DA, Kelsell DP: Gene expression analysis of Epiderm following exposure to SLS using cDNA microarrays. Toxicol In Vitro 2001;15:393-398.
23. Feingold KR, Elias PM: The environmental interface: regulation of permeability barrier homeostasis; in Loden M, Maibach (eds): Dry Skin and Moisturizers. Boca Raton, CRC Press, 2000, pp 45-58.
24. Bouwstra JA, Gooris GS, Dubbelaar FER, Weerheim AM, Ijzerman AP, Ponec M: Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998;39:186-196.
25. Perkins MA, Osborne R, Rana FR, Ghassemi A, Robinson MK: Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol Sci 1999;48:218-229.
26. Roguet R: Use of skin cell cultures for in vitro assessment of corrosion and cutaneous irritancy. Cell Biol Toxicol 1999;15:63-75.
27. Cohen C: Measurement of inflammatory mediators produced by human keratinocytes in vitro: a predictive assessment of cutaneous irritation. Toxicol In Vitro 1991;5:407-410.
28. Bernhofer LP, Barkovic S, Appa Y, Martin KM: IL-1 alpha and IL-1 ra secretion from epidermal equivalents and the prediction of the irritation of mild soap and surfactant-based consumer products. Toxicol In Vitro 1999;13:231-239.
29. Bernhofer LP, Seiberg M, Martin KM: The influence of the response of skin equivalent systems to topically applied consumer products by epithelial-mesenchymal interactions. Toxicol In Vitro 1999;13:219-229.
30. Gay R, Swidderek M, Nelson D, Ernesti A: The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. Toxicol In Vitro 1992;6:303-315.
31. Müller-Decker K, Heinzelmann T, Fürstenberger G, Kecskes A, Lehmann WD, Marks F: Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. Toxicol Appl Pharmacol 1998;153:59-67.
32. Bloom E, Sznitowska M, Polansky J, Ma D, Maibach: Increased proliferation of skin cells by sublethal doses of sodium lauryl sulfate. Dermatology 1994;188:263-268.
33. Elias PM, Feingold KR: Coordinate regulation of epidermal differentation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol 2001;14:28-34.
34. Elias PM, Ansel JC, Woods LC, Feingold KR: Signalling networks in barrier homeostasis: the mystery widens. Arch Dermatol 1996;132:1505-1506.
35. Elias PM, Woods LC, Feingold KR: Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatitis 1999;10:119-126.
36. Fartasch M, Schnetz E, Diepgen TL: Characterization of detergent-induced barrier alterations - Effect of barrier cream on irritation. J Invest Dermatol Symp Proc 1998;3:121-127.
37. Fulmer AW, Kramer GJ: Stratum corneum lipid abnormalities in surfactant-induced dry scaly skin. Soc Invest Dermatol 1986;86:598-602.
38. Fluhr JW, Elias PM: Stratum corneum pH: formation and function of the 'acid mantle'. Exog Dermatol 2002;1:163-175.
39. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. Soc Invest Dermatol 2001;117:44-51.
40. Geilen CC, Barz S, Bektas M: Sphingolipid signaling in epidermal homeostasis. Skin Pharmacol Appl Skin Physiol 2001;14:261-271.
41. Coderch L, de Pera M, Fonollosa J, de la Maza A, Parra JL: Efficacy of stratum corneum lipid supplementation on human skin. Contact Dermatitis 2002;47:139-146.
42. Zellmer S: Hautlipide, Vesikel aus Hautlipiden und ceramidhaltige Liposomen. SÖFW J 2000;126:37-40.
43. Klotz A, Zur Mühlen A, Röcher W, Kirchhof R, Veeger M: Neue Wirkprinzipien für Hautschutzmittel. Berufsgenossenschaft 2002;9:460-463.